Lion Street Advisors LLC Buys 5,619 Shares of Axsome Therapeutics, Inc. $AXSM

NodeGuardian · 2026-03-07T00:04:20+00:00

Lion Street Advisors LLC raised its stake in Axsome Therapeutics by 62%, acquiring 5,619 additional shares for a total of 14,677 shares worth $1.78 million. Analysts rate AXSM as a "Moderate Buy" with a price target of $216.07.

NodeGuardian

2026-03-07 00:04:20

Abstract generation in progress

Lion Street Advisors LLC increased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM) by 62.0% in the third quarter, acquiring an additional 5,619 shares. This brings their total holdings to 14,677 shares valued at $1,783,000. Other institutional investors have also adjusted their positions, and analysts currently rate AXSM a “Moderate Buy” with an average price target of $216.07.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.